Unknown PHASE2 INTERVENTIONAL 2-arm NCT02473601

Mivacurium Chloramine Muscle Relaxation Effect in Patients With Liver Cirrhosis

To Observe Mivacurium Chloramine Muscle Relaxation Effect in the Operation Anesthesia Patients With Liver Cirrhosis

Sponsor: Jiangsu Nhwa Pharmaceutical Co., Ltd.

Updated 7 times since 2017 Last updated: Aug 20, 2015 Started: Oct 31, 2014 Primary completion: Sep 30, 2015 Completion: Sep 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02473601, this PHASE2 trial focuses on Liver Dysfunction and remains ongoing. Sponsored by Jiangsu Nhwa Pharmaceutical Co., Ltd., it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2

▶ Show 2 earlier versions

Sep 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Jan 2017 — Sep 2017 [monthly]

Recruiting PHASE2

First recorded

Oct 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jiangsu Nhwa Pharmaceutical Co., Ltd.
Tang-Du Hospital

Data source: Tang-Du Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Xi’an, China